Therapeutic Hypothermia Modulates S100B and Oxidative Stress in Neonatal Hypoxic-Ischemic Encephalopathy: Implications of SDF4 as a Novel Biomarker.
AIM This study investigated the dynamic profile of stromal cell-derived factor 4 (SDF4), a hypoxia-inducible chemokine and S100B, an established astroglial injury marker, in neonates with hypoxic-ischemic encephalopathy (HIE) undergoing therapeutic hypothermia (TH). Its potential as a biomarker was assessed by examinin...